Medipal Holdings (7459) Price & Analysis

Medipal Holdings Corporation released its earnings results on Nov 05, 2025. The company reported ¥60.63 earnings per share for the quarter, beating the consensus estimate of ¥38.44 by ¥22.19.

Is Medipal Holdings Corporation overvalued?

According to Wall Street analysts Medipal Holdings Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medipal Holdings Corporation pay dividends?

Medipal Holdings Corporation pays a Semiannually dividend of ¥32 which represents an annual dividend yield of 2.32%. See more information on Medipal Holdings Corporation dividends here

What is Medipal Holdings Corporation’s EPS estimate?

Medipal Holdings Corporation’s EPS estimate is 52.52.

How many shares outstanding does Medipal Holdings Corporation have?

Medipal Holdings Corporation has 219,226,040 shares outstanding.

What happened to Medipal Holdings Corporation’s price movement after its last earnings report?

Medipal Holdings Corporation reported an EPS of ¥60.63 in its last earnings report, beating expectations of ¥38.44. Following the earnings report the stock price went up 0.413%.

Which hedge fund is a major shareholder of Medipal Holdings Corporation?

Currently, no hedge funds are holding shares in JP:7459

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medipal Holdings Corporation

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.